FDA staff finds Puma Biotech's cancer drug effective, shares soar

(Reuters) - Shares of Puma Biotechnology Inc surged about 80 percent on Monday after the U.S. Food and Drug Administration staffers concluded after a preliminary review that the company's experimental breast cancer drug was effective.